Learning Objectives:
At the end of this activity, participants should be able to:
- Recognize basic immunologic mechanisms and classifications of autoimmune diseases.
- Identify key characteristics and medications used in common autoimmune disorders.
- Support pharmacy operations related to the preparation, storage, and handling of immunosuppressive therapies.
- Facilitate communication with patients and healthcare providers to support autoimmune treatment plans.
- Assist with inventory, prior authorization, and workflow processes related to specialty autoimmune therapies.
Faculty: Braxton Branick, M.Sc., B.Sc.
The CE faculty, reviewers and planning committee members have all reported no relationships with ineligible companies in relation to this program.
Fees:
FREE for NPTA Insiders/CE+/Elite Members. $10 for Non-members.
Purchases are non-refundable and non-transferable.
Contact Hour(s): 2
Activity Type: Knowledge-based
Target Audience: Certified Pharmacy Technicians
ACPE UAN: 0384-0000-25-043-H01-T
Activity Format: On-Demand Home Study
Release Date: 06/02/2025
Planned Expiration Date: 06/02/2028
CPE Credit Requirements: To receive credit for this ON-DEMAND program, participants must complete the post-test with a passing score of 70%. Participants are given two opportunities to achieve a passing score and receive CPE credit.
System Technical Requirements:
CE activities are delivered via your web browser and/or Adobe Acrobat (PDF). View the minimum technical and system requirements for CE activities.
Support: For questions or support, email us at support@pharmacytechnician.org or call 888-247-8700
If you have questions regarding our privacy/confidentiality policies, please review our Privacy, Data and Terms of Use policy.
NPTA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
© NPTA. All rights reserved. These materials may not be used, in whole or in part, for any purposes, commercial or otherwise, without prior permission in writing from the copyright owner(s).